Drug
Custirsen
Custirsen: highest development phase Phase 3, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| custirsen sodium NCT01083615 | Phase 3 | Castrate-Resistant Prostate Cancer |
Latest
No recent events.
Follow Custirsen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.